Global Radiodermatitis Treatment Market Size, Share & Trends Analysis Report, By Product (Topical, Dressings, Oral, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Stores), Forecast (2022-2028)

The global radiodermatitis treatment market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Radiodermatitis is a medical condition (dermatitis) which is a result of radiation therapy used for the treatment of cancer. Radiodermatitis is commonly seen in approximately 95% of patients who receive radiation therapy, especially patients with breast cancer, head and neck cancer, skin cancer, lung cancer, or sarcoma. The market growth is majorly attributable to the global increase in the prevalence of cancer and thus the rising adoption of radiotherapy as a treatment option. In addition to this, the global rise in the geriatric population base further propels the growth of the global radiodermatitis market.
Some key players operating in the market include 3M Company, Smith & Nephew plc, and ConvaTec Group plc, among others. These players are eyeing on strengthening their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, and so on. For instance, in November 2021, Enveric Biosciences declared that EV102, the Company’s cannabidiol (CBD) based product in development for topical prescription treatment of radiodermatitis, has demonstrated significant and meaningful reduction in dermatitis severity, skin redness, and duration in a preclinical rodent model. EV102 was topically applied during a daily treatment regimen and resulted in a nearly 50% reduction in redness scoring severity. The significance of these preclinical findings will be evaluated in a planned human evaluation in 2022.

Market Coverage
The market number available for – 2021-2028
Base year- 2021
Forecast period- 2022-2028

Segment Covered- 
By Product
By Distribution Channel

Regions covered-
North America
Europe
Asia-Pacific
Rest of the World

Competitive Landscape:
3M Co., Smith & Nephew plc, and ConvaTec Group plc, among others.

Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How are players addressing challenges to sustain growth?
Where is the investment opportunity?

Global Radiodermatitis Treatment Market Report by Segment
By Product
Topical
Dressings
Oral
Others

By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Store